Preclinical Efficacy of CD33 Chimeric Antigen Receptor T Cell Immunotherapy in Childhood Acute Myeloid Leukemia

被引：0
|
作者：
Yang, L. [1 ]
Tarun, S. [1 ]
Shen, F. [2 ,3 ]
Qin, H. [1 ]
Chien, C. D. [1 ]
Kohler, M. L. [1 ]
Fry, T. J. [4 ]
Tasian, S. [2 ,3 ]
机构：
[1] NCI, Pediat Oncol Branch, Bethesda, MD 20892 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[3] Ctr Childhood Canc Res, Philadelphia, PA USA
[4] Univ Colorado Denver, Pediat Hematol & Immunol, Aurora, CO USA
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-100
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [41] Chimeric antigen receptor T cells targeting CD312 as a therapy for acute myeloid leukemia
    Xie, Danni
    Wang, Bing
    Bai, Xue
    Jin, Xin
    Lu, Wenyi
    Zhang, Meng
    Zhang, Yi
    Cao, Xinping
    Zhao, Mingfeng
    CHINESE MEDICAL JOURNAL, 2025, 138 (01) : 114 - 116
  • [42] A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemia
    Hoseini, Sayed Shahabuddin
    Guo, Hongfen
    Wu, Zhihao
    Hatano, Miho Nakajima
    Cheung, Nai-Kong V.
    BLOOD ADVANCES, 2018, 2 (11) : 1250 - 1258
  • [43] Combining Anti-CD33 Chimeric Antigen-Receptor T Cells with the Hypomethylating Agent Decitabine to Treat Acute Myeloid Leukemia
    Ng, Kenneth K. H.
    Del Real, Marissa M.
    Wu, Jonas Jian
    Xue, Tongyuan
    Marcucci, Emanuela
    Yuan, Yate-Ching
    Marcucci, Guido
    Forman, Stephen J.
    Horne, David
    Budde, Lihua E.
    MOLECULAR THERAPY, 2023, 31 (04) : 145 - 146
  • [44] The past and future of CD33 as therapeutic target in acute myeloid leukemia
    Laszlo, George S.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD REVIEWS, 2014, 28 (04) : 143 - 153
  • [45] Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
    Romao, Ema
    Krasniqi, Ahmet
    Maes, Laila
    Vandenbrande, Camille
    Sterckx, Yann G. -J.
    Stijlemans, Benoit
    Vincke, Cecile
    Devoogdt, Nick
    Muyldermans, Serge
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
  • [46] Combinatorial chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
    Mueller, J.
    Myburgh, R.
    Manz, M. G.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 39 - 39
  • [47] Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia
    Malik, Manasi
    Chiles, Joe, III
    Xi, Hualin S.
    Medway, Christopher
    Simpson, James
    Potluri, Shobha
    Howard, Dianna
    Liang, Ying
    Paumi, Christian M.
    Mukherjee, Shubhabrata
    Crane, Paul
    Younkin, Steven
    Fardo, David W.
    Estus, Steven
    HUMAN MOLECULAR GENETICS, 2015, 24 (12) : 3557 - 3570
  • [48] Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
    A Ehninger
    M Kramer
    C Röllig
    C Thiede
    M Bornhäuser
    M von Bonin
    M Wermke
    A Feldmann
    M Bachmann
    G Ehninger
    U Oelschlägel
    Blood Cancer Journal, 2014, 4 : e218 - e218
  • [49] Leukemia targeting via cytotoxic T cells expressing a CD33 specific chimeric receptor.
    Dutour, Aurelie
    Lee, Dean
    Napier, Stephanie
    Finney, Helen
    Pule, Martin
    Choi, William
    Brenner, Malcolm
    Rousseau, Raphael
    BLOOD, 2006, 108 (11) : 138A - 138A
  • [50] Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia
    Ehninger, A.
    Kramer, M.
    Roellig, C.
    Thiede, C.
    Bornhaeuser, M.
    von Bonin, M.
    Wermke, M.
    Feldmann, A.
    Bachmann, M.
    Ehninger, G.
    Oelschlaegel, U.
    BLOOD CANCER JOURNAL, 2014, 4 : e218 - e218
12345